Dr. Reddy's Laboratories Limited share

Dr. Reddy's Laboratories Limited

Live Dr. Reddy's Laboratories Limited Share Price Chart

Dr. Reddy's Laboratories Limited Share Performance

Today's Low Today's High
1,202.85 1,202.60
1,220.40 1220.00
52 Week Low 52 Week High
1,120.00 (04-Jun-2024) 1,120.01 (04-Jun-2024)
1,421.49 (21-Aug-2024) 1,420.20 (21-Aug-2024)

Open
1,218.00 1,212.05
Previous Close
1,209.80 1,211.80
Volume
13.07
Total Traded value
158.52 (Lakhs)
Upper circuit
1,330.75
Lower circuit
1,088.85

Dr. Reddy's Laboratories Limited Share Market Depth

Buy Order Quantity Sell Order Quantity
166
0

Bid PriceQuantity
1,215.85166.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:166
Ask PriceQuantity
0.000.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:--

Dr. Reddy's Laboratories Limited Share Fundamentals

Market Cap: 1,015.37 Cr
PE Ratio (TTM): 19.57
PB Ratio: 3.77
Industry P/E:18.60
Debt to Equity:-
ROE:19.26
EPS (TTM):62.12
Book Value:1,214.78
Face Value: 1.00

Dr. Reddy's Laboratories Limited Stock Financials

Sep, 2023Jun, 2023Mar, 2023Dec, 2022Sep, 2022
Revenue4,838.70 Cr5,437.30 Cr4,554.00 Cr3,897.60 Cr4,880.30 Cr
Profit1,192.60 Cr1,639.40 Cr672.40 Cr324.60 Cr1,116.30 Cr
Expense3,461.20 Cr3,451.30 Cr3,732.20 Cr3,464.10 Cr3,305.40 Cr
Comprehensive income1,132.60 Cr1,678.60 Cr779.90 Cr396.20 Cr1,175.70 Cr
EPS71.5498.4540.4119.5067.10
Dr. Reddy's Laboratories Limited is a global pharmaceutical company that operates with its subsidiaries. The company is involved in various segments, namely Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others.

Under the Global Generics segment, Dr. Reddy's manufactures and markets both prescription and over-the-counter pharmaceutical products. These products are available under brand names or as generic versions that have the same therapeutic effects as branded formulations. Additionally, this segment also focuses on the biologics business.

The PSAI segment of the company is responsible for manufacturing and marketing active pharmaceutical ingredients and intermediates. These ingredients are essential components used in the production of finished pharmaceutical products. The segment also offers contract research services and customizes the manufacturing of active pharmaceutical ingredients and steroids based on specific customer requirements.

The Others segment of Dr. Reddy's is involved in the development of therapies in the fields of oncology and inflammation. It also conducts research and development for differentiated formulations. Furthermore, this segment provides digital healthcare services and information technology-enabled business support services.

The company's therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology.

Dr. Reddy's Laboratories Limited was established in 1984 and has its headquarters in Hyderabad, India.
Company nameListing dateIndustry NSE symbol BSE symbol
Dr. Reddy's Laboratories Limited May, 2003 Pharmaceuticals DRREDDY DRREDDY

Dr. Reddy's Laboratories Limited Stock Shareholding pattern

Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022

  • Promoters 
    26.66%
    Public 
    73.16%
    Shares held by Employee Trusts 
    0.18%
  • Promoters 
    26.69%
    Public 
    73.10%
    Shares held by Employee Trusts 
    0.21%
  • Promoters 
    26.70%
    Public 
    73.08%
    Shares held by Employee Trusts 
    0.22%
  • Promoters 
    26.70%
    Public 
    73.05%
    Shares held by Employee Trusts 
    0.25%
  • Promoters 
    26.71%
    Public 
    73.02%
    Shares held by Employee Trusts 
    0.27%

Dr. Reddy's Laboratories Limited Share FAQ's

What is the range of today's stock performance for Dr. Reddy's Laboratories Limited?

Today's stock performance witnessed a fluctuation from a minimum of 1,202.85 on the NSE (National Stock Exchange) to a maximum of 1,220.40. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,202.60 to a high of 1,220.00.

What are the 52-week low and high values for Dr. Reddy's Laboratories Limited?

The stock's performance over the past 52 weeks reveals a low of 1,120.00 (occurred on 04-Jun-2024) and a high of 1,421.49 (achieved on 21-Aug-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,120.01 (on 04-Jun-2024), and the 52-week high is 1,420.20 (on 21-Aug-2024).

What was the opening and previous closing prices for Dr. Reddy's Laboratories Limited?

The stock's performance over the past 52 weeks reveals a low of 1,120.00 (occurred on 04-Jun-2024) and a high of 1,421.49 (achieved on 21-Aug-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,120.01 (on 04-Jun-2024), and the 52-week high is 1,420.20 (on 21-Aug-2024).

What is the total volume and traded value for Dr. Reddy's Laboratories Limited for the day?

The total volume is 13, and the total traded value is 158.52 ( Lakhs).

What are the upper and lower circuit limits for Dr. Reddy's Laboratories Limited?

The upper circuit limit is 1,330.75, and the lower circuit limit is 1,088.85.

What is the market cap and PE ratio for Dr. Reddy's Laboratories Limited?

The market cap is 1,015.37 Cr, and the PE ratio (TTM) is 18.60.

What is the PB ratio, industry P/E, and debt to equity ratio for Dr. Reddy's Laboratories Limited?

The PB ratio is 1.00, industry P/E is 18.60 .

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Dr. Reddy's Laboratories Limited?

ROE is 19.26, EPS is 62.12, book value is 1,214.78

What are the revenue and profit figures for the latest quarter and previous quarters for Dr. Reddy's Laboratories Limited?

In Sep 2023, Revenue is 48387000000.00, and Profit is 11926000000.00. In Jun 2023, Revenue is 54373000000.00, and Profit is 16394000000.00.

When was Dr. Reddy's Laboratories Limited listed, and what industry does it belong to?

The company, Dr. Reddy's Laboratories Limited, was listed in May 2003 and belongs to the Pharmaceuticals industry. Its NSE symbol is DRREDDY.

What is the current shareholding pattern of the Dr. Reddy's Laboratories Limited?

As of latest available update, promoters hold 26.66%, the public holds 73.16%, and Employee Trusts holds 0.18.

The Indian Community

Public Community

Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.

Members
39
online
95
Threads
235
Settings
Back
Top